Conventus Orthopaedics said it raised $21 million out of a hoped-for $23.1 million for its shoulder and wrist fracture repair technology. Minneapolis-based Conventus is developing a nitinol device that’s designed to expand inside the bone as an internal scaffold to prevent collapse of a shoulder fracture. Another Conventus device also uses nitinol to treat distal fractures of […]
Conventus Orthopaedics, with an FDA clearance in hand, plans a gradual rollout of a new device designed to help repair shoulder fractures in a less invasive way.
Conventus Orthopaedics gained FDA clearance for a device that helps repair shoulder fractures, and will pursue a "measured" U.S. market rollout in the weeks ahead, company officials said.
December 3, 2014 by Brad Perriello
Minnesota medical device maker Conventus Orthopaedics is swapping some executives, naming a new chief executive officer and new chief commercial officer in one fell swoop.
The orthopedics company appointed as its new CEO Paul Buckman, who brought with him years of medtech experience at companies including Boston Scientific and St. Jude Medical. Buckman also co-founded ev3, which Covidien acquired in 2010 for $2.6 billion. Buckman has also served on Conventus’ board of directors since 2009.
Conventus Orthopaedics said the FDA granted 510(k) clearance for its Conventus DRS minimally invasive implant for wrist fractures.
The device is designed to replace traditional volar plate implants used to correct distal radius fractures, requiring a 2-3cm incision on the forearm and "a few tiny incisions at the wrist," according to a press release.